Garedew A: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__TOC__ | |||
{{Person | {{Person | ||
|lastname=Garedew | |lastname=Garedew | ||
|firstname=Assegid | |firstname=Assegid | ||
}} | }} | ||
== Retractions == | |||
:::* [http://retractionwatch.com/2012/09/04/three-retractions-for-university-college-london-mitochondrial-biologist-for-inappropriate-figure-manipulations/ University College London mitochondrial biologist resigns after three retractions for image fraud] | |||
== LinkedIn == | |||
::: From '''https://www.linkedin.com/in/assegid/''' 2017-04-10 | |||
:::: Assa Oumie - Currently Senior Analytical Development Scientist at Cell Therapy Catapult, growing the UK cell and gene therapy industry, delivering health and wealth. Previous to this I worked as a Lead Staff Scientist at Affymetrix UK for an NHS Diagnostic Lab-Academic Research Lab-CRO- Biotech collaborative R&D project, co-funded by the Innovate UK-Stratified Medicine Programme, to develop the OncoScan Assay for tumour genomic profiling. | |||
:::: As a Post Doctoral Researcher of Cell and Molecular Biology at University College London (UCL) I studied cell metabolism and identified therapeutic targets against inflammation and statin-induced myopathy, in collaboration with academic and industrial partners. During my career at UCL I secured funding from research council, charity and pharmaceutical industry for three major research projects, supervised the research projects of students and junior staff and delivered module courses to graduate students. | |||
:::: '''As a Business Development Associate and Post-Doctoral Researcher at Innsbruck Medical University (Austria) in partnership with a spin-out company, I played key roles in cell biology research, oxygen sensor and software development and validation, and customer technical support.''' Before moving to Innsbruck, I worked at the Medical Faculty of the University of WΓΌrzburg (Germany) where I conducted comparative metabolic investigation, on cancer and foetal cells, to better understand the mechanism of adaptation to hypoxia. | |||
::: '''Declaration''' | |||
:::: Assegid Garedew but not Assa Oumie (no person of that name is known to us) was a Postdoc employed by our 'spin-out company' working at the Medical University of Innsbruck (DSL Research Laboratory) after moving to Innsbruck from the University of WΓΌrzburg. ~ [[User:Gnaiger Erich|Gnaiger Erich]] ([[User talk:Gnaiger Erich|talk]]) 14:01, 10 April 2017 (CEST) |
Revision as of 09:25, 15 April 2017
Name | Garedew Assegid, |
---|---|
Institution | |
Address | , |
City | |
State/Province | |
Country | |
Weblink | |
O2k-Network Lab | DE Hamburg Singer D |
Retractions
- From https://www.linkedin.com/in/assegid/ 2017-04-10
- Assa Oumie - Currently Senior Analytical Development Scientist at Cell Therapy Catapult, growing the UK cell and gene therapy industry, delivering health and wealth. Previous to this I worked as a Lead Staff Scientist at Affymetrix UK for an NHS Diagnostic Lab-Academic Research Lab-CRO- Biotech collaborative R&D project, co-funded by the Innovate UK-Stratified Medicine Programme, to develop the OncoScan Assay for tumour genomic profiling.
- As a Post Doctoral Researcher of Cell and Molecular Biology at University College London (UCL) I studied cell metabolism and identified therapeutic targets against inflammation and statin-induced myopathy, in collaboration with academic and industrial partners. During my career at UCL I secured funding from research council, charity and pharmaceutical industry for three major research projects, supervised the research projects of students and junior staff and delivered module courses to graduate students.
- As a Business Development Associate and Post-Doctoral Researcher at Innsbruck Medical University (Austria) in partnership with a spin-out company, I played key roles in cell biology research, oxygen sensor and software development and validation, and customer technical support. Before moving to Innsbruck, I worked at the Medical Faculty of the University of WΓΌrzburg (Germany) where I conducted comparative metabolic investigation, on cancer and foetal cells, to better understand the mechanism of adaptation to hypoxia.
- From https://www.linkedin.com/in/assegid/ 2017-04-10
- Declaration
- Assegid Garedew but not Assa Oumie (no person of that name is known to us) was a Postdoc employed by our 'spin-out company' working at the Medical University of Innsbruck (DSL Research Laboratory) after moving to Innsbruck from the University of WΓΌrzburg. ~ Gnaiger Erich (talk) 14:01, 10 April 2017 (CEST)
- Declaration